Mai Yamauchi

Mai Yamauchi

UNVERIFIED PROFILE

Are you Mai Yamauchi?   Register this Author

Register author
Mai Yamauchi

Mai Yamauchi

Publications by authors named "Mai Yamauchi"

Are you Mai Yamauchi?   Register this Author

53Publications

1459Reads

29Profile Views

Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.

J Natl Cancer Inst 2016 Apr 23;108(4). Epub 2015 Nov 23.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (KI, RN, MY, PL, ZRQ, SAK, KM, YS, YI, CSF, SO); Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD (KI, CCH); Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan (KI); Department of Nutrition (MS, RN, EG, KW), Department of Epidemiology (MS, EG, SO), and Department of Biostatistics (RN), Harvard T. H. Chan School of Public Health, Boston, MA; Channing Division of Network Medicine, Department of Medicine (SJ, XZ, EG, CSF, EC, ATC) and Department of Pathology (SO), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (PL, ATC); Department of Oncology, McGill University, Montreal, Quebec, Canada (MNP); Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (CSM); Section of Endocrinology, Boston VA Healthcare System, Harvard Medical School, Boston, MA (CSM); Department of Dermatology, Warren Alpert Medical School of Brown University, Province, RI (EC).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/108/4/djv363.full.pdf
Web Search
http://jnci.oxfordjournals.org/lookup/doi/10.1093/jnci/djv36
Publisher Site
http://dx.doi.org/10.1093/jnci/djv363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668768PMC
April 2016

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.

Cell Rep 2016 Apr 14;15(4):857-865. Epub 2016 Apr 14.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.03.075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850357PMC
April 2016

Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.

Br J Cancer 2016 Jan 7;114(2):199-206. Epub 2016 Jan 7.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue M420, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815802PMC
January 2016

Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

JAMA Oncol 2015 Aug;1(5):653-61

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts3Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts5Department of Pathology, Brigham and Women's Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.1377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537376PMC
August 2015

RNF43 is frequently mutated in colorectal and endometrial cancers.

Nat Genet 2014 Dec 26;46(12):1264-6. Epub 2014 Oct 26.

1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. [3] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283570PMC
December 2014

Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region.

Am J Clin Nutr 2014 Dec 8;100(6):1479-88. Epub 2014 Oct 8.

From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (RN, ZRQ, MY, KM, YS, SAK, KI, CSF, and SO); the Departments of Nutrition (RN, KW, and ELG), Epidemiology (MW, ELG, SO, and ESS), and Biostatistics (MW), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (MW, XZ, KW, ELG, ATC, CSF, and ESS); the Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan (YB); the Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); and Applied Cancer Research-Institution for Translational Research Vienna, Vienna, Austria (ESS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.114.095539DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232016PMC
December 2014

Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.

J Natl Cancer Inst 2014 Sep 4;106(9). Epub 2014 Sep 4.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (KI, MY, RN, PL, ZRQ, AK, SAK, KM, YS, JAM, CSF, SO); Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD (KI, CCH); Department of Nutrition, Harvard School of Public Health, Boston, MA (RN, AK, KW); Gastrointestinal Research Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK (PL); Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA (SJ, XZ, EC, ATC, CSF); Department of Dermatology, The Warren Alpert Medical School of Brown University, Province, RI (EC); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); Department of Epidemiology, Harvard School of Public Health, Boston, MA (SO); Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA (SO).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161997PMC
September 2014

Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).

Sci Transl Med 2014 Apr;6(233):233re2

Department of Medicine and Case Comprehensive Cancer Center, Case Western Reserve University and University Hospitals Case Medical Center, 10900 Euclid Avenue, Cleveland, OH 44106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3008481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030641PMC
April 2014

Collocation-based sparse estimation for constructing dynamic gene networks.

Genome Inform 2010 ;24:164-78

Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

View Article

Download full-text PDF

Source
January 2014

Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.

J Natl Cancer Inst 2013 Dec 14;105(23):1789-98. Epub 2013 Nov 14.

Affiliations of authors: Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (SO, XL, YI, MY, NJM, KN, RJM, JAM, CSF); Department of Pathology (SO), Channing Division of Network Medicine, Department of Medicine (DS, CSF), and Department of Surgery (MMB), Brigham and Women's Hospital and Harvard Medical School, Boston, MA (SO); Department of Epidemiology (SO, DS) and Department of Biostatistics (DS) , Harvard School of Public Health, Boston, MA; Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC (DN); Memorial Sloan-Kettering Cancer Center, New York, NY (LBS); Hôpital du Sacré-Coeur de Montréal, Montreal, Canada (RW); Loyola University Stritch School of Medicine, Maywood, IL (AH); current: Edward Cancer Center, Naperville, IL (AH); Northwestern University, Chicago, IL (ABB); Toledo Community Hospital Oncology Program, Toledo, OH (RBM); Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848984PMC
December 2013

Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations.

J Natl Cancer Inst 2013 Dec 7;105(24):1852-61. Epub 2013 Dec 7.

Affiliations of authors: Division of Cancer Epidemiology, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD (HN); Channing Division of Network Medicine, Department of Medicine (HN, DJH, ELG, CSF, ATC) and Department of Epidemiology (DJH, PK, ELG, SO), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Center for Molecular Oncologic Pathology (TM, YI, AK, MY, SO), Department of Medical Oncology (TM, MS, YI, AK, MY, CSF, SO, MLF), and Department of Biostatistics and Computational Biology (LW), Dana-Farber Cancer Institute, Boston, MA; Department of Epidemiology (DJH, ELG, SO) and Department of Nutrition, Harvard School of Public Health, Boston, MA (DJH, ELG); Broad Institute, Program in Medical and Population Genetics, Cambridge, MA (MLF); Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA (ATC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866156PMC
December 2013

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

J Natl Cancer Inst 2013 Aug 22;105(15):1151-6. Epub 2013 Jul 22.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735463PMC
August 2013

A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification.

Am J Epidemiol 2013 Jul 20;178(1):84-100. Epub 2013 Jun 20.

Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Epidemiology, Harvard School of Public Health, 450 Brookline Avenue, Room JF-215C, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/aje/kws431DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698990PMC
July 2013

Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.

Cancer Epidemiol Biomarkers Prev 2013 Jun 29;22(6):1142-52. Epub 2013 Apr 29.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681847PMC
June 2013

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.

Eur J Cancer 2012 Dec 26;48(18):3405-13. Epub 2012 Jul 26.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.06.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613860PMC
December 2012

Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.

Int J Cancer 2012 Sep 19;131(5):1169-78. Epub 2011 Nov 19.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, and Department of Medicine Brigham and Women's Hospital, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.26495
Publisher Site
http://dx.doi.org/10.1002/ijc.26495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288809PMC
September 2012

Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.

Clin Cancer Res 2012 Sep 2;18(17):4753-63. Epub 2012 Jul 2.

Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Ave., Room JF-215C, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624899PMC
September 2012

Colorectal cancer: a tale of two sides or a continuum?

Gut 2012 Jun 5;61(6):794-7. Epub 2012 Apr 5.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2012-302014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345045PMC
June 2012

Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.

Clin Cancer Res 2012 Apr 22;18(8):2257-68. Epub 2012 Feb 22.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2410DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628835PMC
April 2012

Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study.

J Natl Cancer Inst 2012 Mar 6;104(5):415-20. Epub 2012 Feb 6.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr542DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295745PMC
March 2012

TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.

PLoS One 2011 20;6(9):e25062. Epub 2011 Sep 20.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0025062PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176811PMC
February 2012

Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.

JAMA 2011 Apr;305(16):1685-94

Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2011.513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087286PMC
April 2011

RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway.

J Biol Chem 2011 Mar 6;286(11):9097-106. Epub 2011 Jan 6.

Department of Molecular Oncology, Graduate School of Medicine and Dentistry, Tokyo Dental and Medical University, 1-5-45 Yushima Bunkyo-ku Tokyo 113-8519, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.165605DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058986PMC
March 2011

STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers.

Clin Cancer Res 2011 Mar 10;17(6):1452-62. Epub 2011 Feb 10.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2694DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077111PMC
March 2011

MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.

Cancer Causes Control 2011 Feb 8;22(2):301-9. Epub 2010 Dec 8.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-010-9698-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278857PMC
February 2011

A state space representation of VAR models with sparse learning for dynamic gene networks.

Genome Inform 2010 Jan;22:56-68

Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

View Article

Download full-text PDF

Source
January 2010

Predicting differences in gene regulatory systems by state space models.

Genome Inform 2008 ;21:101-13

Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
July 2009

Theme: oncology--molecular mechanisms determining the efficacy of EGF receptor-specific tyrosine kinase inhibitors help to identify biomarker candidates.

Biomark Med 2009 Apr;3(2):139-51

Division of Systems Biomedical Technology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/bmm.09.9
Publisher Site
http://dx.doi.org/10.2217/bmm.09.9DOI Listing
April 2009

Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle.

Cancer Sci 2007 Sep 26;98(9):1491-7. Epub 2007 Jul 26.

Departement of Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2007.00534.xDOI Listing
September 2007

Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1.

Clin Cancer Res 2006 Oct;12(19):5841-9

Department of Surgery and Bioengineering, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-06-0750DOI Listing
October 2006

Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages.

Blood 2006 Sep 18;108(6):1849-56. Epub 2006 May 18.

Division of Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo 108-8639, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-016030DOI Listing
September 2006

Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.

Arterioscler Thromb Vasc Biol 2006 Sep 22;26(9):2019-26. Epub 2006 Jun 22.

Division of Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo 108-8639, Japan.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/01.ATV.0000233336.53
Publisher Site
http://dx.doi.org/10.1161/01.ATV.0000233336.53574.a1DOI Listing
September 2006